Participants 25 62 3
seven subjects with autistic disorder
Participants 386 570 8
Seven subjects, ages 6-18 years, with autistic disorder completed a 10-week double-blind, crossover trial of clomipramine and desipramine following a 2-week single-blind, placebo phase
Participants 842 949 3
Parents of all seven subjects elected to have their children continue to take clomipramine after the study.
